Search

Start Over Keyword IMMUNIZATION

  • Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination

    Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination
    Authors:Xuemin Chen, Emory UniversityHe-Ying Sun, Emory UniversityChun Yi Li, Emory UniversityChristina Rostad, Emory UniversityJessica Trost, Emory UGA Ctr Excellence Influenza Res & SurveillRodrigo B Abreu, University of GeorgiaMichael A Carlock, University of GeorgiaJason R Wilson, Centers for Disease Control and Prevention, AtlantaShane Gansebom, Centers for Disease Control and Prevention, AtlantaTed M Ross, University of GeorgiaDavid Steinhauer, Emory UniversityEvan Anderson, Emory UniversityLarry Anderson, Emory University
    Date:2022
    Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Development of a measure to assess vaccine confidence among men who have sex with men

    Development of a measure to assess vaccine confidence among men who have sex with men
    Authors:Paula Frew, Emory UniversityIan W Holloway, University of California, Los AngelesCameron Goldbeck, University of California, Los AngelesDiane Tan, University of California, Los AngelesElizabeth Wu, University of California, Los AngelesJuan Jauregui, University of California, Los AngelesVincent L Fenimore, Emory UniversityLaura A Randall, Emory UniversityChelsea S Lutz, Emory UniversityJudith Mendel, National Vaccine Program Office, WashingtonAnn L Aikin, National Vaccine Program Office, WashingtonGlen J Nowak, University of GeorgiaRobert Bednarczyk, Emory University
    Date:2018
    Publisher:TAYLOR & FRANCIS LTD
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial 4.0 International

  • Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge

    Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
    Authors:Andrey Romanyuk, Georgia Institute of TechnologyRuixue Wang, University of Maryland, RockvilleAlexander Marin, University of Maryland, RockvilleBenjamin M Janus, University of Maryland, RockvilleEric Felner, Emory UniversityDengning Xia, Georgia Institute of TechnologyYenny Goez-Gazi, Texas Biomedical Research InstituteKendra J Alfson, Texas Biomedical Research InstituteAbdul S Yunus, University of Maryland, RockvilleEric A Toth, University of Maryland, RockvilleGilad Ofek, University of Maryland, RockvilleRicardo Carrion Jr, Texas Biomedical Research InstituteMark Prausnitz, Emory UniversityThomas RR Fuerst, University of Maryland, RockvilleAlexander K Andrianov, University of Maryland, Rockville
    Date:2023
    Publisher:MDPI
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Vaccine confidence among people who use drugs: A cross-sectional survey

    Vaccine confidence among people who use drugs: A cross-sectional survey
    Authors:Paula Frew, Emory UniversityJay T Schamel, University of NevadaLaura A Randall, University of NevadaAdrian R King, University of NevadaAnne Spaulding, Emory UniversityElizabeth Wu, University of California Los AngelesIan W Holloway, University of California Los Angeles
    Date:2022
    Publisher:TAYLOR & FRANCIS INC
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years

    Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years
    Authors:Anne M Hause, Centers for Disease Control and Prevention COVID-19 Response TeamDavid K Shay, Centers for Disease Control and Prevention COVID-19 Response TeamNicola P Klein, Kaiser Permanente Northern CaliforniaWinston E Abara, Centers for Disease Control and Prevention COVID-19 Response TeamJames Baggs, Centers for Disease Control and Prevention COVID-19 Response TeamMargaret M Cortese, Centers for Disease Control and Prevention COVID-19 Response TeamBruce Fireman, Kaiser Permanente Northern CalifJulianne Gee, Centers for Disease Control and Prevention COVID-19 Response TeamJason M Glanz, Kaiser Permanente ColoradoKristin Goddard, Kaiser Permanente Northern CaliforniaKayla E Hanson, Marshfield Clinic Research InstituteBrandon Hugueley, Centers for Disease Control and Prevention COVID-19 Response TeamTat’Yana Kenigsberg, Centers for Disease Control and Prevention COVID-19 Response TeamElyse O Kharbanda, HealthPartners InstituteBruno Lewin, Kaiser Permanente Southern CaliforniaNed Lewis, Kaiser Permanente Southern CaliforniaPaige Marquez, Centers for Disease Control and Prevention COVID-19 Response TeamTanya Myers, Centers for Disease Control and Prevention COVID-19 Response TeamAllison Naleway, Kaiser Permanente NorthwestJennifer C Nelson, Kaiser Permanente Washington Health Research InstituteJohn R Su, Centers for Disease Control and Prevention COVID-19 Response TeamDeborah Thompson, Food and Drug Administration, Silver Spring, MarylandBabatunde Olubajo, Centers for Disease Control and Prevention COVID-19 Response TeamMatthew Oster, Emory UniversityEric S Weintraub, Centers for Disease Control and Prevention COVID-19 Response TeamJoshua TB Williams, Denver Health & Hospital AuthorityAnna R Yousaf, Centers for Disease Control and Prevention COVID-19 Response TeamOusseny Zerbo, Kaiser Permanente Northern CalifBicheng Zhang, Centers for Disease Control and Prevention COVID-19 Response TeamTom T Shimabukuro, Centers for Disease Control and Prevention COVID-19 Response Team
    Date:2022
    Publisher:AMER ACAD PEDIATRICS
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Epidemiology of Invasive Haemophilus influenzae Serotype a Disease-United States, 2008-2017

    Epidemiology of Invasive Haemophilus influenzae Serotype a Disease-United States, 2008-2017
    Authors:Monica Farley, Emory UniversityHeidi M Soeters, Centers for Disease Control and Prevention (CDC), AtlantaSara E Oliver, Centers for Disease Control and Prevention (CDC), AtlantaIan D Plumb, Centers for Disease Control and Prevention (CDC), AtlantaAmy E Blain, Centers for Disease Control and Prevention (CDC), AtlantaTammy Zulz, Arctic Investigations Program, CDC, AnchorageBrenna C Simons, Arctic Investigations Program, CDC, AnchorageMeghan Barnes, Colorado Dept Publ Hlth & EnvironmLee H Harrison, Johns Hopkins Bloomberg Sch Publ HlthRuth Lynfield, Minnesota Department of Health, St. PaulStephanie Massay, Alaska Division of Public HealthJoseph McLaughlin, Alaska Division of Public HealthAlison G Muse, New York State Department of HealthSusan Petit, Connecticut Department of Public HealthWilliam Schaffner, Vanderbilt UniversityAnn Thomas, Oregon Health AuthoritySalina Torres, New Mexico Department of Health, Santa FeJames Watt, California Department of Public HealthTracy Pondo, Centers for Disease Control and Prevention (CDC), AtlantaMelissa J Whaley, Centers for Disease Control and Prevention (CDC), AtlantaFang Hu, Centers for Disease Control and Prevention (CDC), AtlantaXin Wang, Centers for Disease Control and Prevention (CDC), AtlantaElizabeth Briere, Emory UniversityMichael G Bruce, Arctic Investigations Program, CDC
    Date:2021
    Publisher:OXFORD UNIV PRESS INC
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model

    Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model
    Authors:Zach Menne, Emory UniversityVasilis C Pliasas, Emory-UGA CenterRichard Compans, Emory UniversitySheniqua Glover, Auburn UniversityConstantinos S Kyriakis, Emory-UGA CenterIoanna Skountzou, Emory University
    Date:2021
    Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Is It Time for Coronavirus Disease-2019 Vaccine Mandates?

    Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
    Authors:Henry H Bernstein, Hofstra NorthwellVeronica Valentine McNally, Michigan State UniversityWalter Orenstein, Emory University
    Date:2022
    Publisher:MOSBY-ELSEVIER
    Publication Version:Final Published Version

  • Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

    Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
    Authors:Joseph R Francica, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBarbara J Flynn, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaKathryn E Foulds, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAmy T Noe, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAnne P Werner, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaIan Moore, Emory UniversityMatthew Gagne, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaTimothy S Johnston, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaCourtney Tucker, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaRachel L Davis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBritta Flach, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaSarah O'Connell, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaShayne F Andrew, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaEvan Lamb, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDillon R Flebbe, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaSaule T Nurmukhambetova, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMitzi M Donaldson, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaJohn-Paul M Todd, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAlex Lee Zhu, MITCaroline Atyeo, MITStephanie Fischinger, MITMatthew J Gorman, MITSally Shin, MITVenkata Viswanadh Edara, Childrens Healthcare Atlanta & Emory UnivKatharine Floyd, Childrens Healthcare Atlanta & Emory UnivLilin Lai, Emory UniversitySeyhan Boyoglu-Barnum, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaRenee Van de Wetering, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAlida Tylor, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaElizabeth McCarthy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaValerie Lecouturier, Sanofi PasteurSophie Ruiz, Sanofi PasteurCatherine Berry, Sanofi PasteurTimothy Tibbitts, Sanofi PasteurHanne Andersen, BIOQUAL Inc.Anthony Cook, BIOQUAL Inc.Alan Dodson, BIOQUAL Inc.Laurent Pessaint, BIOQUAL Inc.Alex Van Ry, BIOQUAL Inc.Marguerite Koutsoukos, GSKCindy Gutzeit, GSKI-Ting Teng, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaTongqing Zhou, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDapeng Li, Duke UniversityBarton F Haynes, Duke UniversityPeter D Kwong, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAdrian McDermott, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMark G Lewis, BIOQUAL Inc.Tong Ming Fu, Sanofi PasteurRoman Chicz, Sanofi PasteurRobert van der Most, GSKKizzmekia S Corbett, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMehul Suthar, Emory UniversityGalit Alter, MITMario Roederer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaNancy J Sullivan, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDaniel C Douek, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBarney S Graham, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDanilo Casimiro, Sanofi PasteurRobert A Seder, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
    Date:2021
    Publisher:AMER ASSOC ADVANCEMENT SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination

    Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination
    Authors:Paul A Gastañaduy, Centers for Disease Control and Prevention, AtlantaJames L Goodson, Centers for Disease Control and Prevention, AtlantaLakshmi Panagiotakopoulos, Centers for Disease Control and Prevention, AtlantaPaul A Rota, Centers for Disease Control and Prevention, AtlantaWalter Orenstein, Emory UniversityManisha Patel, Emory University
    Date:2021
    Publisher:OXFORD UNIV PRESS INC
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International